Sharper Imaging, Smarter Tools: Inside the MonacoPro
With its combination of UWF imaging, OCT integration, and intelligent review tools, the MonacoPro represents the next step in comprehensive retinal evaluation. By improving image quality, enhancing diagnostic confidence, and streamlining workflow, the system supports clinicians in delivering more efficient, informed, and patient-centered care.
Clinical Scorecard: Sharper Imaging, Smarter Tools: Inside the MonacoPro
At a Glance
Category
Detail
Condition
Retinal and choroidal diseases, glaucoma, diabetic retinopathy, systemic diseases affecting the retina
Key Mechanisms
Integration of 200° ultrawidefield (UWF) scanning laser ophthalmoscopy and spectral-domain OCT imaging with intelligent analysis tools and a large reference database
Target Population
Patients requiring retinal evaluation including those with glaucoma, diabetes, hypertension, neurologic disorders, children, and patients with mobility challenges
Care Setting
Primary eye care, large population screening, ophthalmology clinics, telemedicine programs
Key Highlights
MonacoPro captures up to 80% of the retina with 200° UWF imaging and combines it with high-resolution OCT to detect 29.4% more macular pathology than UWF alone.
AreaAssist tool automates lesion measurement and sensitivity adjustment, improving workflow and diagnostic confidence.
Multimodal imaging (color, red-free, choroidal views, green autofluorescence, and OCT) enables comprehensive retinal assessment without pupil dilation.
Guideline-Based Recommendations
Diagnosis
Use combined UWF and OCT imaging to enhance detection of peripheral and macular retinal pathology.
Employ multimodal imaging including autofluorescence and spectral-domain OCT for detailed assessment of optic nerve, macula, and lesions.
Leverage the large reference database for comparison with age-matched normals to identify potential pathology.
Management
Utilize AreaAssist for lesion mapping and longitudinal comparison to monitor disease progression.
Apply OptosAdvance software for accurate measurement and historical overlay in chronic conditions like glaucoma and diabetes.
Use imaging data to limit unnecessary referrals and expedite treatment decisions.
Monitoring & Follow-up
Perform serial imaging to track changes in retinal lesions and glaucoma-related structural changes.
Use multimodal imaging to assess treatment effectiveness and disease progression.
Capture images quickly without dilation to facilitate frequent monitoring.
Risks
No specific risks detailed; device designed for safe use across diverse patient populations including those with limited mobility or photophobia.
Patient & Prescribing Data
Patients undergoing retinal evaluation including those with chronic systemic diseases affecting the eye and patients with mobility or cooperation challenges
MonacoPro imaging supports early detection and monitoring of retinal diseases, enabling timely intervention and reducing delays in care.
Clinical Best Practices
Incorporate MonacoPro imaging as a baseline for future OCT scans to enhance longitudinal assessment.
Use the AreaAssist tool to automate lesion delineation and improve diagnostic accuracy.
Perform imaging without pupil dilation to increase patient comfort and throughput.
Leverage the device’s ADA-compliant design and adjustable features to accommodate diverse patient needs.
Utilize the extensive reference database to contextualize findings and guide clinical decisions.